ALX Homeobox 4 (ALX4) (Middle Region) Peptide
Quick Overview for ALX Homeobox 4 (ALX4) (Middle Region) Peptide (ABIN973161)
Target
Origin
Source
Application
- 
    - 
                                            Protein Region
- Middle Region
- 
                                            Sequence
- EPELPPDSEP VGMDNSYLSV KETGAKGPQD RASAEIPSPL EKTDSESNKG
- 
                                            Characteristics
- This is a synthetic peptide designed for use in combination with anti-Alx4 Antibody(ARP36820_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 
                                            Purification
- Purified
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Lyophilized
- 
                                            Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 
                                            Concentration
- 1 mg/mL
- 
                                            Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- 
                                            Handling Advice
- Avoid repeated freeze-thaw cycles.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
 
- 
                                            
- 
    
- 
                    
 
                                     
                                     
                                    